TBPH - Theravance drops as late-stage trial for COPD therapy Yupelri fails
2024-01-05 06:54:29 ET
More on Theravance Biopharma
- Theravance Biopharma, Inc. (TBPH) Q3 2023 Earnings Call Transcript
- Theravance Biopharma signs cooperation agreement with Irenic Capital
- Theravance Biopharma Q3 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Theravance Biopharma
- Historical earnings data for Theravance Biopharma
For further details see:
Theravance drops as late-stage trial for COPD therapy Yupelri fails